In this commentary, we recapitulate the study by Gabrielson and colleagues, recently published in Cancer Immunology Research, addressing the role of intratumoral CD3<sup>+</sup> and CD8<sup>+</sup> T cells as well as as prognostic markers for hepatocellular carcinoma. The gene discussed is CD8A; the disease is hepatocellular carcinoma.